Acarbose partially prevents the development of diabetes mellitus by multiple low-dose streptozotocin administration

Diabetes Research and Clinical Practice

Volumn 33, Issue 1, 1996, Pages 15-19

  Negishi, Mayumi ^a   Shimizu, Hiroyuki ^a   Ohtani, Ken Ichi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Acarbose; Diabetes mellitus; Insulitis; Streptozotocin

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; GLUCOSE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN;

EID: 0030174937     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01254-5     Document Type: Article

References (21)

1. [1] Gotfredsen, C., Buschard, K. and Frandsen, E. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28, 933-935.
2. [2] Atkinson, M.A., Maclaren, N.K. and Luchetta, R. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39, 933-937.
3. [3] Keller, R.J., Eisenbarth, G.S. and Jackson, R.A. (1993) Insulin prophylaxis in individual at high risk of type I diabetes. Lancet 341, 927-928.
4. [4] Rossini, A.A., Appel, M.C. and Like, A.A. (1977) Genetic influence of the steptozotocin-induced insulitis and hyperglycemia. Diabetes 26, 916-920.
5. [5] Leitter, E.H. (1982) Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57B1 mice: influence of inbred background and sex, and thymus. Proc. Natl. Acad. Sci. U.S.A. 79, 630-634.
6. [6] Rossini, A., Mordes, J. and Like, A. (1985) Immunology of insulin-dependent diabetes mellitus. Ann. Rev. Immunol. 3, 289-320.
7. [7] McEvoy, R.C., Andersson, J., Sandler, S. and Hellerstein, C. (1984) Multiple low-dose streptozotocin-induced diabetes in the mouse: evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J. Clin. Invest. 74, 715-722.
8. [8] Kiesel, U. and Kolb, H. (1983) Suppressive effect of antibodies to immune response gene products on the development of low-dose streptozotocin-induced diabetes. Diabetes 32, 869-871.
9. [9] Nedergaard, M., Edeberg, J. and Kromann, H. (1983) Irradiation protects against pancreatic islet degeneration and hyperglycemia following streptozotocin treatment of mice. Diabetologia 24, 382-386.
10. [10] Puls, W., Keup, U., Krause, H.P., Muller, L., Schmidt, D.D., Thomas, G. and Trsceit, E. (1980) Pharmacology of a glucosidase inhibitor. Front. Hormone Res. 7, 235-247.
11. [11] Puls, W., Keup, U., Krause, H.P., Thomas, G. and Hoffmeister, F. (1977) Glucosidase inhibition: a new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwisseenschften 64, 536-537.
12. [12] Slonim, A.E., Surber, M.L., Page, D.L., Sharp, R.A. and Burr, I.M. (1983) Modification of chemically induced diabetes in rats by vitamin E. J. Clin. Invest. 71, 282-1288.
13. [13] Karasik, A. and Hattori, M. (1994) Use of animal models in the study of diabetes. In: C.R. Kahn and G.C. Weir (Eds.), Joslin's Diabetes, pp. 317-350.
14. [14] Spinas, G.A., Palmer, J.P., Mandrup-Poulsen, T., Andersen, H., Nielsen, J.H. and Nerup, J. (1988) The bimodal effect of interleukin-1 on rat pancreatic beta-cell-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol. 119, 307-311.
15. [15] Palmer, J.P., Helqvist, S., Spinas, G.A., Mølving, J., Mandrup-Poulsen, T., Andersen, H.U., Nielsen, J.H. and Nerup, J. (1989) Interaction of b-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38, 1211-1216.
16. [16] Crisá, L., Mordes, J.P. and Rossini, A.A. (1993) Autoimmune diabete in the BB rat. Diabetes Metab. Rev. 8, 4-27.
17. [17] Zhang, Z.J., Davidson, L., Eisenbarth, G. and Weiner, H.L. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U.S.A. 88, 10252-10256.
18. [18] Nerup, J., Mandrup-Poulsen, T., Mølving, J. and Spinas, G. (1988) Immune interactions with islet cells: implications for the pathogenesis of insulin dependent diabetes mellitus: In: P.J. Lefebvre and D.G. Pipeleers (Eds.), The pathology of the Endocrine Pancreas in Diabetes, Berlin, Springer Verlag, pp. 71-84.
19. [19] Aaen, K., Rygard, J., Josenson, K., Peterson, H., Brogren, C.H., Horn, T. and Buschard, K. (1990) Dependence of antigen expression on functional state of cells. Diabetes 39, 697-701.
20. [20] Bjork, E., Kampe, O., Andersson, A. and Karlsson, F.A. Expression of the 64 K/glutamic acid decarboxylase rat islet autoantigen is influenced by the rate of insulin secretion. Diabetologia 35, 490-493.
21. [21] Bjork, E., Kampe, O., Karlsson, F.A., Pipeleers, D.G., Andersson, A., Hellerström, C. and Eizirok, D.L. (1992) Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J. Clin. Endocrinol. Metab. 75, 1574-1576.